Read the full story in pdf.
Read also:
- Wolfgang Knoll: We dream about scent sensors that work just like our noses.
Making lifesaving discoveries
|
Redactie
Henri Termeer ended up in the world of health care purely by coincidence. After having been headhunted in 1983 by Genzyme, a biotechnology company in Boston, he stood at the helm for almost three decades. He pioneered the market and economy for drugs and therapies for patients with rare diseases, the so-called orphan drugs. The biomedical industry was up and coming and Termeer broke new ground to safeguard these orphan drugs for the future.
